Furofuran lignans of Artemisia genus: Isolation, biosynthesis and biological activity
Ickovski Jovana D., Pavlović Jovana Lj., Mitić Milan N. and 4 more
Journal of the Serbian Chemical Society · 2020
doi:10.2298/jsc191210009i (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Since ancient times, medicinal plants and pharmacologically active products obtained from different natural sources play an important role in human health. Plants belonging to the genus Artemisia possess a great biological potential and it is a well-studied genus in the fields such as systematics (including molecular phylogenetics) and genome organization. Many species of the genus (e.g., A. absinthium, A. annua, A. vulgaris, A. abrotanum, A. arborescens) are widely exploited, because of their high economic value as medicines, food and ornamentals. Withal, in such a large genus, some hiatus must inevitably exist, concerning attainments and potentials that individual species possess. Most of the studies are focused on bioactivity and pharmacology of sesquiterpene lactones. Lignans are unjustly neglected, even though they as well exhibit a wide range of bioactivities. Motivated by that fact, we tried to consolidate findings on bioactive lignans accumulated through the years, with the logical perspectives on further work on isolation and identification of new bioactive lignans and the exploitation of lignans as substances of potential pharmacological interest. [Project of the Serbian Ministry of Education, Science and Technological Development, Grant no. 172047]
Abstract licence: CC BY
References173
- 14.
- 29.
- 31.
37 more references, whose wording the paper’s licence keeps private.
All 173 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.